Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".

Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".

Detalhes bibliográficos
Principais autores:	Mavaddat, N, Roalfe, A, Fletcher, K, Lip, G, Hobbs, R, Fitzmaurice, D, Mant, J
Formato:	Journal article
Idioma:	English
Publicado em:	2014

Registros relacionados

Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
por: Mavaddat, N, et al.
Publicado em: (2014)

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
por: Mant, J, et al.
Publicado em: (2007)

Warfarin versus aspirin for prevention of cognitive decline in an elderly community population with atrial fibrillation (the BAFTA Study): a randomised controlled trial
por: Mavaddat, N, et al.
Publicado em: (2013)

Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation.
por: Jowett, S, et al.
Publicado em: (2011)

Is warfarin a safe alternative to aspirin in elderly patients with atrial fibrillation?
por: Mant, J, et al.
Publicado em: (2008)

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
por: Mant, J, et al.
Publicado em: (2003)

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
por: Fletcher Kate, et al.
Publicado em: (2003-08-01)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.
por: Hobbs, F, et al.
Publicado em: (2011)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial
por: Hobbs, R, et al.
Publicado em: (2011)

A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study.
por: Roalfe, A, et al.
Publicado em: (2012)

Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project.
por: Farhan Shahid, et al.
Publicado em: (2018-01-01)

A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.
por: Hurley, V, et al.
Publicado em: (2007)

Impact of study design on recruitment of patients to a primary care trial: an observational time series analysis of the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) study.
por: Fletcher, K, et al.
Publicado em: (2010)

Warfarin versus aspirin for stroke prevention (BAFTA) - Reply
por: Mant, J, et al.
Publicado em: (2007)

The use of warfarin in veterans with atrial fibrillation
por: Rosenbeck Karen, et al.
Publicado em: (2004-10-01)

Anticoagulant management in patients with atrial fibrillation.
por: Fitzmaurice, D, et al.
Publicado em: (2009)

Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial.
por: Mant, J, et al.
Publicado em: (2007)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
por: I. Yu. Koroleva, et al.
Publicado em: (2016-11-01)

Research into practice: management of atrial fibrillation in general practice.
por: Fitzmaurice, D, et al.
Publicado em: (2014)

Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial
por: Chan-Hyuk Lee, et al.
Publicado em: (2019-05-01)

Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis
por: Line Melgaard, et al.
Publicado em: (2021-12-01)

Alcohol and Atrial Fibrillation
por: Stanisław Surma, et al.
Publicado em: (2023-03-01)

Should we screen for atrial fibrillation?
por: Lown, M, et al.
Publicado em: (2017)

Atrial Fibrillation-Related Outcomes [Letter]
por: Naser A
Publicado em: (2024-10-01)

Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
por: Jean Michell Correia Monteiro, et al.

The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.
por: Bungard, T, et al.
Publicado em: (2003)

CAN CLOPIDOGREL FULLY SUBSTITUTE WARFARIN AND DABIGATRAN IN ATRIAL FIBRILLATION?
por: A. B. Sumarokov
Publicado em: (2013-08-01)

Warfarin and its role in the prevention of thromboembolism in atrial fibrillation (lecture)
por: Y. V. Shubik
Publicado em: (2015-12-01)

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
por: Carolina eMalta Hansen, et al.
Publicado em: (2012-06-01)

Characteristics of warfarin under-prescription in older adults with atrial fibrillation
por: Sana Rashid, et al.
Publicado em: (2021-12-01)

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
por: Touchette DR,, et al.
Publicado em: (2008-03-01)

ANTICOAGULATION IN PATIENTS WITH ATRIAL-FIBRILLATION - EXPERT SOFTWARE MAY BE THE ANSWER
por: Fitzmaurice, D, et al.
Publicado em: (1994)

Management of atrial fibrillation
por: Puneet Kakar, et al.
Publicado em: (2007-03-01)

Identifying At‐Risk Patients for Sustained Atrial High‐Rate Episodes Using the C2HEST Score: The West Birmingham Atrial Fibrillation Project
por: Yan‐Guang Li, et al.
Publicado em: (2021-03-01)

SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS
por: E. L. Artanova, et al.
Publicado em: (2016-01-01)

Prevalence of atrial fibrillation in the general population and in high-risk groups: The ECHOES study
por: Davis, R, et al.
Publicado em: (2012)

Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study.
por: Davis, R, et al.
Publicado em: (2012)

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
por: van Walraven, C, et al.
Publicado em: (2009)

Stroke prevention in atrial fibrillation
por: Hobbs, F
Publicado em: (2003)

Patients with Atrial Fibrillation are Unlikely to Benefit from Aspirin Monotherapy
por: Wang N, et al.
Publicado em: (2024-05-01)